-
Ultragenyx Pharmaceutical's (RARE) "Buy" Rating Reaffirmed at Canaccord Genuity Group
来源: Buzz FX / 12 11月 2024 11:39:16 America/Chicago
Ultragenyx Pharmaceutical's (RARE) "Buy" Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat November 12, 2024 Share Link copied to clipboard. Ultragenyx Pharmaceutical ( NASDAQ:RARE - Get Free Report ) 's stock had its "buy"
Read more...